Cover Image


Protein Kinase Inhibitors in Oncology: Analytical Tool

出版商 BioSeeker Group AB 商品編碼 166080
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
分析工具:癌症治療的蛋白激脢抗化劑 Protein Kinase Inhibitors in Oncology: Analytical Tool
出版日期: 2016年08月22日 內容資訊: 英文



  • <調查報告書> 癌症的癌蛋白激脢治療(商品編碼:103311)
    • 第1章 實施摘要
    • 第2章 關於癌症
    • 第3章 調查方法
    • 第4章 目錄
    • 第5章 介紹
    • 第6章 最大的治療效果來提升投資回收率的治療標靶
      • 藥劑重新定位
      • 蛋白激脢治療標靶
      • 癌基因組計劃和蛋白激脢治療標靶
      • 蛋白激脢治療的構造基礎藥劑設計
      • 所特定的蛋白激脢治療標靶間的相互作用
      • 藥劑和標靶的交互作用體
      • 路徑分析
    • 第7章 新產品抬頭
      • 結束的藥劑標靶介紹
      • 登錄前上市準備階段
      • 第3期臨床試驗
      • 第2期臨床試驗
      • 第1期臨床試驗
      • 前臨床試驗
      • 癌治療用蛋白激脢藥劑的介紹
    • 第8章 化合物策略:各種化合物蛋白激脢治療藥的競爭標竿學習
      • 小分子
      • 縮氨酸・蛋白質藥劑
      • 抗體、抗體樣品構造
      • 核酸治療
      • 細胞・基因治療
      • 蛋白激脢治療藥的近似性競爭
      • 蛋白激脢治療標靶的類細胞地方化為基礎的化合物策略
    • 第9章 蛋白激脢治療藥對癌症的適應
      • 急性淋巴性白血病
      • 急性骨髓性白血病
      • 腎上腺癌
      • B細胞淋巴瘤
      • 良性攝護腺肥大症
      • 膽道癌 其他
    • 第10章 投資計畫
    • 第11章 免責事項
    • 第12章 藥劑索引
    • 第13章 企業索引
  • <資料庫>癌治療的蛋白激脢抗化劑生產線:(商品編碼:171785)
    • 臨床試驗負責醫師
    • 藥劑名異名
      • 商標名
      • 非專利藥
      • 編碼名
    • 開發階段
      • 開發中的520個藥劑最新趨勢
      • 已上市
      • 已登錄
      • 登錄前
      • 第3期
      • 第2期
      • 第1期
      • 前臨床
      • 無資料
      • 中斷
      • 中止
    • 適應
    • 標靶
      • 187的標靶分45類
    • 標靶發現介紹
    • 路徑
    • 機制
    • 化合物
    • 藥劑介紹
      • 藥劑名
      • 臨床試驗負責醫師及夥伴
      • 標靶及標靶的分子功能
      • 標靶的部位
      • 標靶發現介紹
      • 標靶訊號路徑
      • 機制
      • 開發計畫
      • 藥劑解說
      • 化合物資料
      • 專利資料
      • 商業及市場
      • 第3期資料
      • 第2期資料
      • 第1期資料
      • 臨床前資料
      • 專利資料
    • 應用特性
    • 系統必要條件
      • Operating system: Windows (2000/XP/Vista/7/8) for Mac Users the service is only available online
      • Browser Application (Internet Explorer, Firefox, Chrome, Safari)
      • Internet access (to access related internet resources)



Product Code: BSG060223

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals from a business development, drug development or investment perspective.

BioSeeker's Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering:

  • Target Scouting
  • Early & Late Stage Pipeline Analysis
  • Biomarker/Companion Diagnostic Analysis
  • Deal & Alliance Analysis
  • Combination Therapy Analysis
  • Indication Selection & Expansion Analysis
  • First-in-Class Analysis
  • Drug Repositioning
  • Pipeline Analysis by Targeted Pathways

Analytical Tools transform your computer's desktop into a high capacity workbench within your area of choice. Even before launching this desktop app you have already eliminated hundreds of hours of work needed to discover, process and piece together the thousands of sources that our team of oncology dedicated and highly experienced contents specialists have done on your behalf. It covers more than 463 companies plus partners who are today developing 1541 protein kinase inhibitors in oncology drugs where of 831 are active in 2912 developmental projects in cancer across 296 different targets. The Analytical Tool and its contents are yours to keep and data can be easily exported into Excel format for mixing with your own proprietary information.

Let our expertise work for you

While executing some of your daily tasks in our Analytical Tools you will benefit from almost two decades of our experience in perfecting features and analysis, allowing you to easily create breakdowns, tables, graphs and exports for your reports, presentations and conference attendance via our easy to use point and click interface.

Support and inspiration at your finger-tips

You also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.

A tool to grow with and keep you informed

Unlike a static report which just represents a particular snapshot in time, all of BioSeeker's Analytical Tools come with one year of free online access to twice-weekly updates in both contents and features (valued at $3375), pipeline alerts and online support. You can choose to renew your access to these updates and support on a yearly basis or go completely online with our industry leading full service platform, 1stOncology.

Your key to accessing the 1stOncology Newsdesk

As a special bonus, your Analytical Tool unlocks lifetime(*) access to the 1stOncology Newdesk! This service, which is normally reserved for full 1stOncology users only, is a live stream of breaking news within the oncology industry. Updated every 5 minutes, you can tune in to specific channels such as Social Media, Clinical Trials, Intellectual Property, Financial data and Press Releases. This is a great tool to ensure your surveillance of your area of interest is complete.

Did you know?

BioSeeker's Analytical Tools are a longstanding series of products powering decision making in oncology since 1999. Transform your computer's desktop to a dedicated oncology workbench today! Request sample pages or order here to ensure you are not missing out on what you need to know.

System Requirements

  • Operating system: Windows (2000/XP/Vista/7/10) for Desktop App and Mac OSX access only via our online service.
  • Browser Application (Internet Explorer, FireFox, Chrome or Safari))
  • Internet access (to access related internet resources)

(*) In this context, lifetime access refers to the full period of time that BioSeeker Group offer a Newsdesk product or similar news based service.

Back to Top